Primecap Management CO Adaptive Biotechnologies Corp Transaction History

Primecap Management CO

$134 Billion
Q3 2024

A detailed history of Primecap Management CO transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Primecap Management CO holds 76,030 shares of ADPT stock, worth $485,831. This represents 0.0% of its overall portfolio holdings.

Number of Shares

76,030

Previous 146,190 47.99%

Holding current value

$485,831

Previous $529,000 26.47%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$3.37 - $5.12 $236,439 - $359,219	-70,160 Reduced 47.99%	76,030 $389,000
Q4 2022 Feb 13, 2023	SELL	$6.26 - $9.34 $26,980 - $40,255	-4,310 Reduced 2.86%	146,190 $1.12 Million
Q2 2022 Aug 11, 2022	SELL	$6.4 - $14.73 $288,000 - $662,850	-45,000 Reduced 23.02%	150,500 $1.22 Million
Q1 2022 May 11, 2022	SELL	$10.12 - $28.9 $50,599 - $144,500	-5,000 Reduced 2.49%	195,500 $2.71 Million
Q4 2021 Feb 11, 2022	SELL	$25.17 - $36.85 $125,850 - $184,250	-5,000 Reduced 2.43%	200,500 $5.63 Million
Q3 2021 Nov 12, 2021	SELL	$30.02 - $39.87 $420,280 - $558,180	-14,000 Reduced 6.38%	205,500 $6.99 Million
Q2 2021 Aug 10, 2021	BUY	$32.22 - $44.59 $289,980 - $401,310	9,000 Added 4.28%	219,500 $8.97 Million
Q1 2021 May 14, 2021	BUY	$37.26 - $67.74 $3.06 Million - $5.55 Million	82,000 Added 63.81%	210,500 $8.48 Million
Q4 2020 Feb 08, 2021	SELL	$45.01 - $65.47 $1.98 Million - $2.88 Million	-44,000 Reduced 25.51%	128,500 $7.6 Million
Q3 2020 Nov 13, 2020	BUY	$35.79 - $48.81 $787,380 - $1.07 Million	22,000 Added 14.62%	172,500 $8.39 Million
Q1 2020 May 14, 2020	BUY	$16.96 - $34.16 $2.55 Million - $5.14 Million	150,500 New	150,500 $4.18 Million

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $913M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account

Primecap Management CO Adaptive Biotechnologies Corp Transaction History